Mary Lynn Morgan Lecture, 2006
2006 Dr. Harriet Robinson
Dr. Harriet Robinson, chief of the Division of Microbiology and Immunology in Yerkes Primate Research Center of Emory University, has been selected as the eighth speaker in the Mary Lynn Morgan Annual Lectureship on Women in the Health Professions. Her talk, "Working Towards an HIV/AIDS Vaccine: Where are we now and where do we want to be?" was presented on Tuesday, October 24, 2006, at 7:30 p.m. in Emory’s Miller-Ward Alumni House.
A pioneer in vaccine development, Dr. Robinson is also the Asa Griggs Candler Professor of Microbiology and Immunology in Emory’s medical school and a faculty member in the Emory Vaccine Center housed at Yerkes.
She is internationally known for her discovery that purified DNA can be used as a safe, effective vaccine. Most recently, she has been the force behind the development of an HIV/AIDS vaccine, currently in human clinical trials. The vaccine, initially developed and tested at Yerkes and licensed to GeoVax, is considered a leading candidate for containing HIV infections and preventing progression to AIDS.
Dr. Robinson received her PhD in microbiology from the Massachusetts Institute of Technology. Prior to joining Emory in 1997, she was a professor at the University of Massachusetts Medical School. Dr. Robinson was a National Science Foundation Fellow and has served on committees of the National Institutes of Health, the U.S. Food and Drug Administration, and the World Health Organization. She currently serves on the Nominating Committee of the American Society of Microbiology, the Board of Governors of the American Academy of Microbiology, as a consultant of the Gates Foundation, and is chief of the GeoVax Scientific Advisory Board.